Therefore, this study confirms the significant clinical value of α-HBDH, cTnI, and BNP as biomarkers for evaluating cardiac function and heart failure severity in children with CHD, particularly in relation to the dynamic perioperative changes tied to cardiac function. This evidence concerns the gene NPPB and heart failure.